IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 241 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,637 | -99.9% | 267,997 | +92.2% | 0.02% | +42.9% |
| Q3 2022 | $1,336,000 | -62.3% | 139,467 | -34.5% | 0.01% | -44.0% |
| Q1 2022 | $3,546,000 | +183.7% | 212,974 | +225.1% | 0.02% | +257.1% |
| Q4 2021 | $1,250,000 | -29.3% | 65,514 | -8.6% | 0.01% | -36.4% |
| Q3 2021 | $1,768,000 | -52.9% | 71,704 | -11.4% | 0.01% | -85.5% |
| Q4 2020 | $3,756,000 | +22.1% | 80,965 | -27.8% | 0.08% | -17.4% |
| Q2 2020 | $3,077,000 | – | 112,098 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |